c-Kit-IN-1 | c-Kit Inhibitor | MedChemExpress
Dasatinib is an Orally Active Dual Bcr-Abl and Src Family Tyrosine Kinase Inhibitor - Network of Cancer Research
Chapter 24 tyrosine kinase inhibitors
Nils Welsh - Department of Medical Cell Biology - Uppsala University, Sweden
Cancers | Free Full-Text | Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance
List of c-Kit inhibitors | Download Table
KIT inhibition by tyrosine kinase inhibitors (TKIs). Imatinib, a type... | Download Scientific Diagram
Various Protein Kinase Inhibitors as Anticancer Agents | Encyclopedia MDPI
c-Kit signalling activates the MAPK and PI3K signalling cascades.... | Download Scientific Diagram
VEGFR2/Flt3/c-Kit Inhibitor The VEGFR2/Flt3/c-Kit Inhibitor, also referenced under CAS 796967-10-7, controls the biological activity of VEGFR2/Flt3/c-Kit. This small molecule/inhibitor is primarily used for Activators/Inducers applications. | 796967-10-7
Figure 3 from Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells | Semantic Scholar
Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain | Oncogene
The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor - ScienceDirect
Discovery of Conformational Control Inhibitors Switching off the Activated c -KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants | Journal of Medicinal Chemistry
Inhibition of c-Kit by tyrosine kinase inhibitors | Haematologica
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors - ScienceDirect
Novelty Nobility Challenges “Development of an AMD Therapeutic Agent with a New Mechanism, c-KIT” - 바이오스펙테이터
The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor
Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition | PNAS
c-Kit-IN-5-1 | c-Kit Inhibitor | MedChemExpress
JCI - MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma
Figure 2 from Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells | Semantic Scholar
Inhibition of c-Kit by tyrosine kinase inhibitors | Haematologica
Figure 1 from Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells | Semantic Scholar
Tyrosine Kinase Inhibitors Induce Down-Regulation of c-Kit by Targeting the ATP Pocket | PLOS ONE
JCI - An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic
c-キッ阻害 | c-Kit Inhibition
